In the News

Share
1496 News Items found
In the Clinic
Shanu Modi
FDA Approves First Targeted Drug to Treat HER2 Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist Shanu Modi.
Q&A
MSK medical oncologist Smita Joshi, who specializes in esophageal cancer.
Esophageal Cancer Risk: The Truth About Hot Drinks Like Coffee and Tea
There is very little evidence that drinking hot beverages increases esophageal cancer risk.
Man putting on sunscreen
Can Tattoos Hide Skin Cancer? Advice From MSK on How To Stay Safe
First, the good news: There’s no evidence that tattoos cause skin cancer, says Memorial Sloan Kettering Cancer Center (MSK) dermatologist Jennifer DeFa...
Memorial Sloan Kettering Cancer Center physician-scientist Richard Wong
Pancreatic Cancer Spreads With Help From Schwann Cells, MSK Researchers Find
Pancreatic cancer cells spread with the help of tracks laid by nerve-supporting cells called Schwann cells.
Feature
Memorial Sloan Kettering Cancer Center radiologist Sandra Brennan, Director of Radiology at MSK Westchester.
Common Breast Lumps That Aren’t Cancer
Learn about the different types of benign breast lumps.
bowl of edamame
Does Eating Soy Increase Estrogen and Cause Breast Cancer?
Learn whether eating soy products causes cancer.
Q&A
Medical oncologist Emily Feld
Metastatic and Metastasized Cancers: Answers to 7 Common Questions
In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.
See Dr. Urvi Shah and Dr. Neil Iyengar, medical oncologists at Memorial Sloan Kettering Cancer Center
Research Shows Plant-Based Diets Are Better Than Ketogenic Diets for Cancer Risk and Long-Term Health
Experts at Memorial Sloan Kettering Cancer Center reviewed the research and found that whole food plant based diets are better than ketogenic diets at reducing cancer risk and helping people after cancer treatment live healthier lives.
SKI molecular biologist John Maciejowski
SKI Study Sheds Light on How a Natural Defense Against Viruses Can Lead to Mutations in Cancer Cells
A protein in the body that protects against viruses can also cause cancer-related mutations.
In the Clinic
Jason Mascolo with his wife, Tricia, and daughter, Maeve
Molecular Testing Leads to Personalized Treatment for a Rare Sarcoma: Jason’s Story
Learn how molecular analysis of Jason’s sarcoma led to a personalized immunotherapy treatment that dramatically improved his prognosis. MSK is a leader in treating sarcoma.